References
- Speirs V, Shaaban AM et al. The rising incidence of male breast cancer. Breast Cancer Res Treat. 2008 may; 115(2): 429-30. PubMed | Google Scholar
- Yoney A, Kucuk A, Unsal M et al. Male breast cancer: a retrospectiveanalysis. Cancer/Radiothérapie. 2009 apr; 13(2): 103-107. PubMed | Google Scholar
- Sellal N, Haddad H, Bouchbika Z, Benchakroun N,
Jouhadi H,Tawfiq N, Sahraoui S, Benider A. Cancer du sein: l'homme estaussi
concerné:
tude de 21 cas. Andrologie. 2011; 21(1): 45-51.
é Google
Scholar
- Bourhafour M, Belbaraka R, Souadka A, M'rabti H,
Tijami F, Errihani H. Male breast cancer: a report
of 127 cases at a Moroccan institution. BMC Research Notes. 2011 jun29;
4: 219. PubMed | Google
Scholar
- Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF et al. Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010 apr; 28(12): 2114-2122. PubMed | Google Scholar
- Brinton LA, Key TJ, Kolonel LN et al. Prediagnostic
sex steroid hormones in relation to male breast cancer
risk. J Clin Oncol. 2015 jun; 33(18): 2041-50. PubMed | Google
Scholar
- PDQ Adult Treatment Editorial Board. Male Breast Cancer Treatment (PDQ). Health professional Version. 2016 Feb 12. PubMed | Google Scholar
- Cutuli B, Cohen-Solal Le-Nir C, Serin D, Kirova Y, Gaci Z, Lemanski C, Male breast cancer et al. Evolution of treatment and prognostic factors: Analysis of 489 cases. Crit Rev Oncol Hematol. 2010 mar; 73(3): 246-254. PubMed | Google Scholar
- Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008 Feb; 371(9612): 569-578. PubMed | Google Scholar
- Sonnenblick EB, Salvatore M, Szabo J, Lee KA, Margolies LR. Incremental role of mammography in the evaluation of gynecomastia in men who have undergone chest CT. AJR Am J Roentgenol. 2016 Aug; 207(2): 234-40. PubMed | Google Scholar
- NCCN (National Comprehensive Cancer Network) Breast Cancer Guidelines.
- Weiss JR, Moysich KB, Swede H. Epidemiology of male breastcancer. Cancer Epidemiol Biomarkers Prev. 2005 Jan; 14(1): 20-26. PubMed | Google Scholar
- Yu E, Stitt L, Vujovic O, Joseph K, Assouline A, Younus J et al. Male breast cancer prognostic factors versus female counterparts with propensity scores and matched-pair analysis. Cureus. 2015 Oct; 7(10): e355. PubMed | Google Scholar
- Evans DG, Bulman M, Young K, Howard E, Bayliss S, Wallace A et al. BRCA1/2 mutation analysis in male breast cancer families from North West England. Fam Cancer. 2008; 7(2): 113-117. PubMed | Google Scholar
- Zhu J, Davis CT, Silberman S, Spector N, Zhang T. A role for the androgen receptor in the treatment of male breast cancer. Crit Rev Oncol Hematol. 2016 Feb; 98: 358-363. PubMed | Google Scholar
- Farrow J, Adair F. Effect of orchiectomy on
skeletal metastases from cancer of the male breast.
Science. 1942 Jun; 95(2478): 654. PubMed | Google
Scholar
- Volm Matthew D. Male breast cancer. Curr Treat Optios Oncol. 2003 Apr; 4(2): 159-164. PubMed | Google Scholar
- Laabadi K et al. Cancer du sein de l'homme: à propos de 6 cas. Pan Afr Med J. 2013 Oct; 16: 70. PubMed | Google Scholar
- Abreu MH et al. Male breast cancer: Looking for better prognostic subgroups. The Breast. 2015; 26: 18-24. PubMed | Google Scholar
- Masci G et al. Clinicopathological and immunohistochemical
characteristics in male breast cancer: a retrospective
case series. Oncologist. 2015 Jun; 20(6): 586-592. PubMed | Google
Scholar